EGFR and lung cancer: In addition, the metabolic pathway of arachidonic acid is linked to the biological basis of lung cancer due to the involvement of biosynthetic cyclooxygenases (COX-2) and phospholipase A2 (PLA2) in the MAPK/ERK and EGFR pathways [36].